Microbot Medical Inc. (MBOT)


-0.10 (-4.74%)
Symbol MBOT
Price $2.01
Beta 3.145
Volume Avg. 3.60M
Market Cap 19.620M
Shares () -
52 Week Range 1.0-6.33
1y Target Est -
DCF Unlevered MBOT DCF ->
DCF Levered MBOT LDCF ->
ROE 1878.12% Strong Buy
ROA 1203.81% Strong Buy
Operating Margin -
Debt / Equity 30.84% Neutral
P/E -1.18 Sell
P/B 2 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest MBOT news

Mr. Harel Gadot
Medical Instruments & Supplies
NASDAQ Capital Market

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.